-
Health Advisory: Update on Measles Cases
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Immunization, Immunizations, Measles, News and Alerts, News and Alerts, News and Update, Notifiable Conditions06/05/2025 Action Requested Background Measles illness starts with a prodrome of fever, cough, coryza, and conjunctivitis (typically lasting 2-4 days) and then a generalized maculopapular rash that typically begins on the face/head then spreads to the neck, trunk and extremities. Increases in measles cases and outbreaks are occurring in every region of the world. CDC…
-
Health Advisory: Increase in Syphilis Cases in Yakima County
Requested Actions Be aware, Yakima County reported a 326% increase in syphilis cases in 2021 compared to 2020. Optimize syphilis surveillance in pregnancy to reduce the risk of congenital syphilis. Test all women in the first trimester or at presentation to care if presenting after the first trimester Test all high-risk women again in the…
-
03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings
Advisory or Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email…
-
02/25/22 Health Advisory: COVID-19 Updates for Providers
Requested actions Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a…
-
02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review
COVID-19 Updates for Providers Requested actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster…
-
Urgent Notice: New Communicable Disease Fax Line
Communicable Disease Data Report, Health Alert, News and Alerts, News and Update, Notifiable ConditionsThe Communicable Disease department at the Yakima Health District has a new fax line to report notifiable conditions and communicable diseases. The new fax line is (509) 381-3526. The Yakima Health District investigates approximately 100 communicable diseases and conditions that are reportable to the local health jurisdiction. To report a notifiable condition, use the Notifiable…
-
Uninsured Care Expansion Grant and Patient Resources for Individuals Experiencing Long COVID-19
Requested Actions Be aware the Health Care Authority (HCA) has received $35 million in federal resources for the provision of health care services for uninsured and underinsured individuals under 200 percent of the federal poverty level, regardless of immigration status. Be aware the University of Washington Medicine has a Post-COVID-19 Rehabilitation and Recovery clinic to…
-
02/01/22 Health Advisory: FDA Provides Full Approval For Spikevax
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Notifiable Conditions, Provider Resources, UncategorizedCOVID-19 Updates for Providers Requested actions Be aware, U.S. Food and Drug Administration (FDA) granted full authorization to Moderna COVID-19 vaccine for people 18 years or older. Evidence shows the vaccine is safe and effective and manufactured with high quality. The vaccine will now be called Spikevax but has the same formulation as emergency use…
-
01/06/22 Health Advisory: Booster Eligibility Expanded
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) decision to strongly recommend a single Pfizer COVID-19 vaccine booster dose for people 12–17 years old at least 5 months after their primary series. This expands the age of booster access and strengthens…
-
Health Advisory: COVID-19 Isolation and Quarantine Update
01/05/2022 Requested actions Be aware the CDC has indicated the guidance released last week was intended for the general public, and they will be releasing additional I&Q guidance for some congregant settings soon. Be aware WA DOH recommends that people staying, working/learning in the following settings continue to follow existing DOH and CDC guidance until…
-
01/04/22 Health Advisory: CDC updated antiviral guidance
Advisory or Update, COVID-19, Health Advisory, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and…
-
12/14/21: Health Advisory: COVID-19 Updates for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Immunization, Immunizations, News and Alerts, News and Update, Notifiable Conditions, Provider Resources, Schools, TravelCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend everyone 16 years or older get a COVID-19 vaccine booster dose at the recommended interval. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer-BioNTech…
-
Provider Alert – Boil Water Advisory for City of Selah
**Clinical leadership is expected to schedule time to review guidelines with staff** Provider Alert – Boil Water Advisory for City of Selah 12/10/2021 Actions Requested Screen patients for E. coli based on recent travel into or residence in City of Selah Symptoms of E. coli infection include severe stomach cramps, diarrhea (often bloody), and…